Renal Pelvis and Ureter Urothelial Carcinoma
Associated Genetic Biomarkers
NCI Definition: A transitional cell carcinoma that arises from the renal pelvis and ureter. 
There are 3 clinical trials for renal pelvis and ureter urothelial carcinoma, of which 3 are open and 0 are completed or closed. Of the trials that contain renal pelvis and ureter urothelial carcinoma as an inclusion criterion, 2 are phase 2 (2 open) and 1 is phase 3 (1 open).
Pembrolizumab, bcg vaccine, and atezolizumab are the most common interventions in renal pelvis and ureter urothelial carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.